Nasdaq IPOs

Riding the momentum of last year’s strong initial public offerings (IPOs) activity, Nasdaq ushered in 91 companies with a 76% overall win rate in the first month of 2021, as companies continue to bet on a robust market in the new year.

Viant Technology, which provides programmatic advertising software, announced terms for its IPO on Monday. The Irvine, CA-based company plans to raise $150 million by offering 7.5 million shares at a price range of $19 to $21. At the midpoint of the proposed range, Viant Technol

Lucira Health, which is developing single-use test kits for COVID-19 and other infectious diseases, announced terms for its IPO on Monday. The Emeryville, CA-based company plans to raise $125 million by offering 7.8 million shares at a price range of $15 to $17. At the midpoint

Bolt Biotherapeutics, a Phase 1/2 biotech developing targeted therapies for solid tumors, announced terms for its IPO on Monday. The Redwood City, CA-based company plans to raise $150 million by offering 8.8 million shares at a price range of $16 to $18. At the midpoint of the p

Pharvaris, a Dutch Phase 1 biotech developing small molecule therapies for rare diseases, announced terms for its IPO on Monday. The Leiden, Netherlands-based company plans to raise $125 million by offering 7 million shares at a price range of $17 to $19. At the midpoint of the

SportsTek Acquisition, a blank check company targeting the sports and related sectors, filed on Monday with the SEC to raise up to $125 million in an initial public offering. The Tulsa, OK-based company plans to raise $125 million by offering 12.5 million units at $10. Each unit

Newbury Street Acquisition, a blank check company targeting a tech business in the consumer internet or media space, filed on Monday with the SEC to raise up to $150 million in an initial public offering. The Boston, MA-based company plans to raise $150 million by offering 15 mi

FTAC Hera Acquisition, the eighth blank check company formed by management of The Bancorp to acquire a fintech business, filed on Monday with the SEC to raise up to $750 million in an initial public offering. The Philadelphia, PA-based company plans to raise $750 million by offe

MCAP Acquisition, a blank check company formed by Monroe Capital targeting technology, filed on Monday with the SEC to raise up to $250 million in an initial public offering. The Chicago, IL-based company plans to raise $250 million by offering 25 million units at $10. Each unit

Twelve Seas Investment II, a blank check company targeting global companies located outside the US, filed on Monday with the SEC to raise up to $250 million in an initial public offering. The Los Angeles, CA-based company plans to raise $250 million by offering 25 million units

Angion Biomedica, a Phase 3 biotech developing small molecule therapies for acute organ injuries, announced terms for its IPO on Monday. The company had previously filed to raise $30 million in May 2014 but withdrew the following October, citing market conditions. The Union

Sensei Biotherapeutics, a Phase 2 biotech developing bacteriophage-based therapies for cancer, announced terms for its IPO on Monday. The Rockville, MD-based company plans to raise $100 million by offering 5.9 million shares at a price range of $16 to $18. At the midpoint of the

Vor Biopharma, a Phase 1/2 biotech developing cell therapies for hematological diseases, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $150 million by offering 8.8 million shares at a price range of $16 to $18. At the midpoint of the propo

Terns Pharmaceuticals, a Phase 2 biotech developing small molecule therapies for NASH, announced terms for its IPO on Monday. The Foster City, CA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the midpoint of the propo

Immunocore Holdings, a Phase 3 biotech developing T cell therapies for cancer and other diseases, announced terms for its IPO on Monday. The Abingdon, UK-based company plans to raise $200 million by offering 8.3 million ADSs at a price range of $23 to $25. The company plans to r

The IPO market is expected to remain active in the week ahead with nine IPOs scheduled to raise $2.7 billion.  Canadian digital service provider TELUS International (TIXT) plans to raise $800 million at a $6.4 billion market cap. The company provides customer service outsou

The first month of 2021 closed out with eight IPOs, 24 SPACs, and one postponement. Three issuers raised more than $1 billion, bringing the count of billion-dollar US IPOs in January to six, the most in a single month ever. Just one IPO submitted an initial filing ahead of the Fe

Alpha Capital Acquisition, a blank check company targeting technology businesses in Latin America, filed on Friday with the SEC to raise up to $200 million in an initial public offering. The New York, NY-based company plans to raise $200 million by offering 20 million units at $

CF Acquisition VI, the sixth blank check company formed by Cantor Fitzgerald, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million units at $10. Each unit consist

Longview Acquisition II, the second blank check company formed by executives at healthcare-focused hedge fund Glenview Capital, filed on Friday with the SEC to raise up to $500 million in an initial public offering. The New York, NY-based company plans to raise $500 million by o